$NTLA #ATTR News: Intellia announces plans to present interim clinical results from its ongoing Phase 1 study for NTLA-2001 at the 2021 Peripheral Nerve Society (PNS) Annual Meeting. Read more: https://t.co/pJUsCOd2NF @PNSociety1 #amyloidosis #CRISPR #genomeediting #PNS2021 https://t.co/Ch5nounw6h